BioCentury | Aug 17, 2017
Finance

Built to purpose

...Quanticel Pharmaceuticals Inc. Celgene Corp. (NASDAQ:CELG) Versant Ventures Cancer Platform $55 (A) $485 2011 2015 Annovation Biopharma Inc....
...leveraged from the option holder’s R&D capabilities, such as with Quartet. In 2010, Atlas spun Annovation Biopharma Inc....
BioCentury | Apr 20, 2015
Finance

X marks the spot for Atlas

...seen four IPOs and six M&A events, most recently the acquisition of asset-centric anesthesia play Annovation Biopharma Inc....
BioCentury | Mar 23, 2015
Strategy

Show me the value

...Meanwell said. One example is an ongoing Phase I study of the anesthetic ABP-700 at Annovation Biopharma Inc....
BioCentury | Feb 5, 2015
Company News

The Medicines Co. acquires Annovation

...The Medicines Co. (NASDAQ:MDCO) exercised its option to acquire Annovation Biopharma Inc. (Cambridge, Mass.) for $28.4 million in...
BioCentury | Oct 6, 2014
Finance

Atlas' next chapter

...SIX:ATLN), Allschwil, Switzerland Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Annovation Biopharma Inc....
...active portfolio have deals under which a program or the entire company could be acquired: Annovation Biopharma Inc....
BioCentury | Jan 20, 2014
Finance

Asset-centric milestone

...candidates that have crossed its radar ( see BioCentury, Oct. 8, 2012 ). The second, Annovation Biopharma Inc....
...investors may be brought on." Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Annovation Biopharma Inc....
BioCentury | Sep 17, 2012
Company News

Annovation Biopharma board of directors update

Annovation Biopharma Inc. , Cambridge, Mass. Business: Neurology Appointed: Carl Berke, partner at Partners Innovation Fund; Jason Campagna, VP of global health and medical outcomes at The Medicines Co. ; and Jean Francois Formela, partner at...
BioCentury | Sep 17, 2012
Finance

Hitting the books

...Hitting the books Anesthesia play Annovation Biopharma Inc. is the second company to emerge from Atlas Venture 's...
BioCentury | Sep 17, 2012
Financial News

Annovation Biopharma completes venture financing

Annovation Biopharma Inc. , Cambridge, Mass. Business: Neurology Date completed: 9/10/12 Type: Venture financing Raised: $8 million Investors: Atlas Venture; Partners Innovation Fund; The Medicines Co. Note: Annovation said the round may be expanded to up...
BioCentury | Sep 11, 2012
Company News

Annovation debuts to develop anesthetics

Annovation Biopharma Inc. debuted to develop anesthetics with $8 million in a series A round from Atlas Venture; Partners Innovation Fund; and The Medicines Co. (NASDAQ:MDCO). Annovation is working on small molecule GABA-A receptor agonists...
Items per page:
1 - 10 of 10
BioCentury | Aug 17, 2017
Finance

Built to purpose

...Quanticel Pharmaceuticals Inc. Celgene Corp. (NASDAQ:CELG) Versant Ventures Cancer Platform $55 (A) $485 2011 2015 Annovation Biopharma Inc....
...leveraged from the option holder’s R&D capabilities, such as with Quartet. In 2010, Atlas spun Annovation Biopharma Inc....
BioCentury | Apr 20, 2015
Finance

X marks the spot for Atlas

...seen four IPOs and six M&A events, most recently the acquisition of asset-centric anesthesia play Annovation Biopharma Inc....
BioCentury | Mar 23, 2015
Strategy

Show me the value

...Meanwell said. One example is an ongoing Phase I study of the anesthetic ABP-700 at Annovation Biopharma Inc....
BioCentury | Feb 5, 2015
Company News

The Medicines Co. acquires Annovation

...The Medicines Co. (NASDAQ:MDCO) exercised its option to acquire Annovation Biopharma Inc. (Cambridge, Mass.) for $28.4 million in...
BioCentury | Oct 6, 2014
Finance

Atlas' next chapter

...SIX:ATLN), Allschwil, Switzerland Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Annovation Biopharma Inc....
...active portfolio have deals under which a program or the entire company could be acquired: Annovation Biopharma Inc....
BioCentury | Jan 20, 2014
Finance

Asset-centric milestone

...candidates that have crossed its radar ( see BioCentury, Oct. 8, 2012 ). The second, Annovation Biopharma Inc....
...investors may be brought on." Companies and Institutions Mentioned Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Annovation Biopharma Inc....
BioCentury | Sep 17, 2012
Company News

Annovation Biopharma board of directors update

Annovation Biopharma Inc. , Cambridge, Mass. Business: Neurology Appointed: Carl Berke, partner at Partners Innovation Fund; Jason Campagna, VP of global health and medical outcomes at The Medicines Co. ; and Jean Francois Formela, partner at...
BioCentury | Sep 17, 2012
Finance

Hitting the books

...Hitting the books Anesthesia play Annovation Biopharma Inc. is the second company to emerge from Atlas Venture 's...
BioCentury | Sep 17, 2012
Financial News

Annovation Biopharma completes venture financing

Annovation Biopharma Inc. , Cambridge, Mass. Business: Neurology Date completed: 9/10/12 Type: Venture financing Raised: $8 million Investors: Atlas Venture; Partners Innovation Fund; The Medicines Co. Note: Annovation said the round may be expanded to up...
BioCentury | Sep 11, 2012
Company News

Annovation debuts to develop anesthetics

Annovation Biopharma Inc. debuted to develop anesthetics with $8 million in a series A round from Atlas Venture; Partners Innovation Fund; and The Medicines Co. (NASDAQ:MDCO). Annovation is working on small molecule GABA-A receptor agonists...
Items per page:
1 - 10 of 10